1. Malátková, Petra, Ebert, Bettina, Wsól, Vladimír, Maser, Edmund. 2012. Expression of human carbonyl reductase 3 (CBR3; SDR21C2) is inducible by pro-inflammatory stimuli. In Biochemical and biophysical research communications, 420, 368-73. doi:10.1016/j.bbrc.2012.03.002. https://pubmed.ncbi.nlm.nih.gov/22425771/
2. Blanco, Javier G, Leisenring, Wendy M, Gonzalez-Covarrubias, Vanessa M, Stovall, Marilyn, Bhatia, Smita. . Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. In Cancer, 112, 2789-95. doi:10.1002/cncr.23534. https://pubmed.ncbi.nlm.nih.gov/18457324/
3. Liu, Shilong, Zhan, Ning, Gao, Chunzi, Piao, Shiqi, Jing, Suwei. 2021. Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 /miR-409-3p/SOD1 axis. In Cancer letters, 526, 1-11. doi:10.1016/j.canlet.2021.11.009. https://pubmed.ncbi.nlm.nih.gov/34801596/
4. Hou, Min, Wu, Nannan, Yao, Lili. 2021. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion. In Cancer cell international, 21, 36. doi:10.1186/s12935-020-01685-y. https://pubmed.ncbi.nlm.nih.gov/33422081/